Warning letter
Foothills Professional Pharmacy, LTD: warning letter of Sep 9, 2020
FDA warning letter 598883 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 598883 |
|---|---|
| Company | Foothills Professional Pharmacy, LTD |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Sep 9, 2020 |
| Posted date | Sep 29, 2020 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 211.42(c), 211.110(a), 211.160(b), 210.1(b), 211.166(a), 211.165(a), 201.115, 211.63, 211.192, 200.10(b) |
| Inspection city | Phoenix |
| Inspection ZIP | 85048-7644 |
| Inspection start date | Jul 9, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: